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Toll-like receptor (TLR) signal transduction is a central component of the innate immune response to
pathogenic challenge. Although recent studies have begun to elucidate differences in acquired immunity in
tissues of the human female reproductive tract, there is a relative paucity of work regarding innate defense
mechanisms. We investigated TLR mRNA and protein expression in tissues of the human female reproductive
tract. Constitutive mRNA expression of TLRs 1 to 6 was observed in fallopian tubes, uterine endometrium,
cervix, and ectocervix. Furthermore, transcripts of the signaling adapter MyD88 and the accessory molecule
CD14 were also detected in all tissues assayed. Quantitative analysis of TLR2 mRNA levels revealed highest
expression of this molecule in fallopian tube and cervical tissues, followed by endometrium and ectocervix. In
contrast to TLR2, TLR4 expression declined progressively along the tract, with highest expression in the upper
tissues (fallopian tubes and endometrium), followed by cervix and ectocervix. In addition to mRNA, protein
expression of TLR2 and TLR4 was also documented in these tissues. These data suggest that TLRs are
differentially expressed in distinct compartments of the female reproductive tract and may provide insight
regarding the regulation of inflammation and immunity within the tract.
The human female reproductive tract is immunologically
unique in that it must tolerate allogeneic sperm and permit
implantation and fetal development while simultaneously detecting and responding to a broad diversity of sexually transmitted pathogens. To accommodate these disparate functions,
the female reproductive tract relies upon both innate and acquired immune defense mechanisms. Thus, the epithelial cells,
macrophages, lymphocytes, and dendritic cells present within
the female genital tract possess unique features which permit
them to respond to a distinct microbiotic milieu (13). To mediate these responses, the innate immune system has evolved
to recognize distinct products of microbial metabolism present
on a wide variety of microorganisms. These conserved products, termed pathogen-associated molecular patterns, are recognized by a repertoire of invariant pattern recognition receptors (8, 13).
Many functions of innate immunity are transduced through
pattern recognition receptors; recent studies impute a critical
role to one particular group of pattern recognition receptors,
the evolutionarily conserved mammalian Toll-like receptor
(TLR) family of proteins (14). These type I transmembrane
receptors are characterized by a leucine-rich extracellular domain and a conserved intracellular activation domain, which is
homologous to the interleukin-1 receptor and has thus been
designated the Toll/interleukin-1 receptor domain (3). Binding
of an activated Toll/interleukin-1 receptor domain to the
adapter protein MyD88 initiates a signaling cascade, leading to

NF-B activation and the subsequent production of proinflammatory and immunoregulatory cytokines, chemokines, and costimulatory molecules (3).
Of the 10 cloned mammalian TLRs, TLR2 and TLR4 are
the best characterized with respect to innate responses to bacteria. TLR4, in association with accessory molecules MD-2 and
CD14, is the signal transduction receptor for gram-negative
bacterial lipopolysaccharide and heat shock proteins (16, 18,
19, 20, 24, 32). A broader range of microbial products activate
immune responses through engagement of TLR2, including
peptidoglycan from gram-positive bacteria (15), bacterial lipopeptides (15), and zymosan (17).
Given the microbial diversity of the human female reproductive tract and the significant role that TLRs play in mediating innate immune recognition, we investigated Toll-like receptor expression in the fallopian tube, uterus, cervix, and
ectocervix. Constitutive expression of TLRs 1 to 6 as well as the
accessory molecule CD14 and the molecular adapter MyD88
was observed throughout the female reproductive tract. With
real-time reverse transcription-PCR, we demonstrated distinct
patterns of TLR2 and TLR4 mRNA expression in these tissues. TLR2 and TLR4 proteins were also detected in each of
these tissues, indicating efficient translation of these transcripts. These findings definitively establish TLR expression
within the human female genital tract and implicate TLRmediated immune surveillance as an important component of
defense in the female reproductive tract.

* Corresponding author. Mailing address: Department of Physiology, Dartmouth Medical School, Lebanon, NH 03756. Phone: (603)
650-8105. Fax: (603) 650-6130. E-mail: pioli@dartmouth.edu.
† Present address: Baylor Institute for Immunology Research, Dallas, TX 75204.

Reproductive tract tissues. Human tissues were obtained immediately following surgery from patients from whom informed consent was obtained. Donors
ranged in age from 26 to 81 years and were treated for a diversity of gynecologic
maladies. All tissues used in these studies were distal to sites of pathology and
were determined to be unaffected with disease at the gross anatomical level.

MATERIALS AND METHODS
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TABLE 1. PCR primers used for amplification of pattern recognition receptors

Primer

Forward sequence (5⬘–3⬘)

Reverse sequence (5⬘–3⬘)

TLR1
TLR2
TLR3
TLR4
TLR5
TLR6
MyD88
MD2
CD14

ATTTCATATAGTGGGCACGATTC
GGCCAGCAAATTACCTGTGTG
CCTGGTTTGTTAATTGGATTAACGA
CAGAGTTTCCTGCAATGGATCA
TGCCTTGAAGCCTTCAGTTATG
GAAGAAGAACAACCCTTTAGGATAGC
GAGCGTTTCGATGCCTTCAT
ATTCCAAGGAGAGATTTAAAGCAATT
CGCTCCGAGATGCATGTG

AAAGAGATT GTGATGGGCAAAGT
AGGCGGACATCCTGAACCT
TGAGGTGGAGTGTTGCAAAGG
GCTTATCTGAAGGTGTTGCACAT
CCAACCACCACCATGATGAG
AGGCAAACAAAATGGAAGCTT
CGGATCATCTCCTGCACAAA
CAGATCCTCGGCAAATAACTTCTT
TTGGCTGGCAGTCCTTTAGG

Approval to use human tissues was obtained from the Human Experimentation
Committee in accordance with the human experimentation guidelines of the U.S.
Department of Health and Human Services.
RNA isolation and reverse transcription-PCR. Total RNA was isolated from
tissue by sequential extraction with Trizol reagent (Invitrogen) followed by purification with RNeasy mini columns (Qiagen). RNA integrity was confirmed by
agarose gel electrophoresis, and RNA was quantified by spectrophotometric
analysis. Prior to amplification, all RNA samples were treated with RNase-free
DNase I (Qiagen) to preclude genomic DNA contamination. With 500 ng of
RNA as the template for each reaction, first-strand cDNA was synthesized with
random primers and SuperScript II Moloney murine leukemia virus reverse
transcriptase (Invitrogen). PCR analysis was performed with Taq DNA polymerase for 35 cycles in a PCR Express Gradient thermocycler (Hybaid) with the
primer pairs delineated in Table 1. Cycling conditions were as follows: 2 min of
initial denaturation at 95°C, followed by 35 cycles, each of which consisted of 30 s
at 94°C, 30 s at 57°C, and 45 s at 72°C, followed by a final extension at 72°C for
5 min. Reactions were amplified in the absence of reverse transcriptase as
negative controls. A nontemplate control reaction was also included to ensure
lack of DNA contamination; 10 l of PCR product was electrophoresed on a
1.5% agarose gel with 0.5% ethidium bromide and photographed under UV
light.
TaqMan PCR. For quantification of TLR2 and TLR4 expression in tissues of
the female reproductive tract, TaqMan PCR analysis was employed; 0.5 l per
well of cDNA was transferred into i-Cycler 96-well plates (Bio-Rad), and TaqMan Master Mix (Applied Biosystems) was added in accordance with the manufacturer’s instructions. The primer pairs used for amplification of TLR2 were
(5⬘-3⬘) GGC CAG CAA ATT ACC TGT GTG and AGG CGG ACA TCC TGA
ACC T, and those for TLR4 were (5⬘-3⬘) CAG AGT TTC CTG CAA TGG ATC
A and GCT TAT CTG AAG GTG TTG CAC AT.
TaqMan MGB probes (labeled with fluorescent reporter dye 6FAM) were
used for analysis of TLR2 (TCC ATC CCA TGT GCG TGG CC) and TLR4
(CGT TCA ACT TCC ACC AAG AGC TGC CT). Input cDNA was normalized
with a validated predeveloped assay reagent ␤-actin primer probe pair (Applied
Biosystems) as an internal control. Amplification was performed on an iCycler
with an optical unit (Bio-Rad) that permits real-time monitoring of increased
PCR product concentration. Threshold cycle number was determined with the
Opticon software and levels of TLR mRNA expression were normalized to
␤-actin levels with the formula 2 ⫺ ⫺(Et⫺Rt), where Rt is the mean threshold cycle
for the reference gene (␤-actin) and Et is the mean threshold cycle for the
experimental gene. Relative fluorescence units (RFU) were assigned to these
values, and these data were used to generate the expression profiles delineated
in the text. The thermal profile for TaqMan PCR consisted of 2 min at 50°C and
10 min at 95°C, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min.
Amplicon accumulation was measured during the extension phase. All reactions
were performed in duplicate. Data were analyzed with the iCycler analysis
software, version 2.3. (Bio-Rad).
Immunoprecipitation and immunoblotting. Cell lysates were prepared by mechanical disruption of snap-frozen tissue in T-PER lysis reagent (25 mM Bicine,
150 mM NaCl, pH 7.6) (Pierce) with a mortar and pestle. Samples were centrifuged at 10,000 rpm for 5 min to pellet cell debris, and supernatants were
collected, aliquoted, and stored at ⫺80°C. Protein concentrations were determined by the BCA protein assay (Pierce). TLR2 was immunoprecipitated from
1 mg of each protein lysate with a rabbit polyclonal anti-TLR2 antibody (H-175)
(Santa Cruz Biotechnology). Immunoprecipitation of TLR4 was performed with
a mouse monoclonal anti-TLR4 antibody (HTA 125) (Santa Cruz Biotechnology). Immune complexes were captured with protein A/G-Sepharose beads
(Pierce) for 2 h at 4°C, and the beads were washed four times with 100 mM NaCl.

To ensure the specificity of protein-antibody interaction, lysates were incubated with beads in the absence of antibody as well as with an irrelevant P3
immunoglobulin G1 isotype control (Caltag). Proteins were resolved by sodium
dodecyl sulfate (SDS)-10% polyacrylamide gel electrophoresis (PAGE) and
electrotransferred to nitrocellulose membrane in Tris-glycine buffer, with 20%
methanol. Immunoblots were washed with 1⫻ phosphate-buffered saline–0.05%
Tween 20 and blocked in 5% milk for 1 h at room temperature. Membranes were
then probed with goat polyclonal antibody N-17 (Santa Cruz Biotechnology) for
detection of TLR2, followed by donkey anti-goat horseradish peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology). TLR4 was detected by
probing immunoprecipitates with rabbit polyclonal anti-TLR4 antibody H-80
(Santa Cruz Biotechnology), followed by goat anti-rabbit horseradish peroxidase-conjugated secondary antibody (Bio-Rad). Reactive antigens were visualized with Supersignal chemiluminescence substrate (Pierce).
Statistical Analysis. Data are represented as mean ⫾ standard deviation.
Comparisons among tissue types were made with paired tissue samples derived
from the same patient. The sample size for each comparison is indicated in the
upper right quadrant of each figure. For each paired graphical representation,
the RFU value of the tissue type represented in the first column was set to 1
(divided by itself), and the values of the second column are represented as a
fraction of the first-column values. Statistical analysis was performed on the RFU
values of each pair of columns with a paired t test with two-tailed P values.
Statistical significance was achieved at P ⱕ 0.05.

RESULTS
Tissues of the human female reproductive tract express
TLR family members 1 to 6 as well as adaptor molecule
MyD88 and accessory molecules CD14 and MD2. Although
previous work has described the distribution of TLRs 2 and 4
in the mouse genital tract (4, 6), a comprehensive analysis of
TLR mRNA expression in human tissues of the female reproductive tract has not been reported. Given the fundamental
role attributed to TLRs in mediating innate immunity and the
broad scope of microbial challenges encountered by the female
reproductive tract, initial studies examined the TLR mRNA
expression profiles of the fallopian tube, uterine endometrium,
cervix, and ectocervix. Total RNA was extracted from homogenized whole tissue and analyzed for TLR expression by reverse transcription-PCR. As presented in Fig. 1, mRNA expression of TLRs 1 to 6 was detected in all four tissue types.
In addition to ligand engagement, recruitment of the adaptor molecule MyD88 is required for most TLR-mediated signal
transduction (25, 26). Moreover, biochemical and genetic evidence indicates that complex formation with the bacterial coreceptor CD14 is necessary for maximal activation of TLR2
and TLR4 signaling (10, 32) and suggests a similar requirement for MD-2 association (for MyD88-dependent TLR4 signaling) (24). Significantly, all tissues analyzed demonstrated
mRNA expression of these molecules (Fig. 1).
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FIG. 1. mRNA expression of TLRs, MyD88, MD-2, and CD14 in
tissues of the female reproductive tract. Total RNA was extracted from
fallopian tube, endometrial, cervical and ectocervical tissues, reverse
transcribed, and amplified with the primers described in Table 1 for
expression of pattern recognition receptors. For each tissue, the data
shown are representative of gene expression observed in 10 different
patient samples.

mRNA expression levels of TLR2 and TLR4 in human female reproductive tract tissues. Bacterial infection within the
female genital tract can have potentially devastating consequences, including chronic inflammation and infertility (11,
23). Innate immunity mediated by TLR2 and TLR4 signaling
may provide a means of detecting and responding to these
pathogens. As our preliminary studies confirmed mRNA expression of TLR2 and TLR4 in female reproductive tract tis-
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sue, we next quantified transcript levels of these receptors with
TaqMan PCR. To determine if quantitative differences in
mRNA expression levels were evident in different regions of
the female reproductive tract, tissues derived from the same
patient were compared in pairs, and statistical analysis performed. TLR mRNA expression levels were normalized to
␤-actin; we validated utilization of this gene by analyzing relative expression among tissues of the human female reproductive tract. The data shown in Fig. 2 (in which ␤-actin mRNA
expression of each tissue type is represented by threshold cycle) indicated minimal variability in ␤-actin mRNA levels.
Figure 3 shows TaqMan real-time quantitative PCR analysis
of TLR2 expression in tissues of the human female reproductive tract. Striking and significant differences were observed
with respect to TLR2 mRNA levels in some of the tissues
examined. In particular, TLR2 expression was significantly
lower in endometrium than in either fallopian tube or cervix
(Fig. 3A and 3B). While the mean for endometrial TLR2
expression was also lower than that of ectocervix (Fig. 3C), this
was not statistically significant. There was also no significant
difference between fallopian tube and cervical TLR2 expression (Fig. 3D), but the disparity in mRNA levels between
cervix and ectocervix—as well as between fallopian tube and
ectocervix—was significant (Fig. 3E and F). Although normalization was essential for the above comparison of composite
data for TLR2 expression in multiple samples from different
tissues (Fig. 3), these differences are perhaps better appreciated by examination of RFU values without normalization, as
presented for a representative patient sample (see Fig. 5A).

FIG. 2. Validation of ␤-actin as a normalization control. Total RNA was extracted from each female reproductive tract tissue, reverse
transcribed, and analyzed by TaqMan PCR with validated ␤-actin primers and probe (as described in the text). Comparisons were made with tissue
samples derived from the same patient to maintain internal consistency; therefore, four individual patients from whom fallopian tube (FT),
endometrium (EM), cervix (CX), and ectocervix (ECX) samples were obtained are represented in this study. All reactions were performed in
triplicate.
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FIG. 3. TLR2 mRNA is most highly expressed in fallopian tubes and cervix. Total RNA was isolated from the fallopian tube (FT), endometrium
(EM), cervix (CX), and ectocervix (ECX) as described in the text, and reverse transcription was performed with random hexamers. Comparisons
among tissue types were made with paired tissue samples derived from the same patients. The sample size for each comparison is indicated in the
upper right quadrant of each figure. Real-time PCR analysis of relative TLR2 mRNA expression was performed in duplicate with TaqMan TLR2and ␤-actin-specific primers and probes. Samples incubated in the absence of reverse transcriptase were analyzed as well to control for genomic
DNA contamination.

To determine whether or not TLR4 transcript levels mirrored those observed with TLR2, real-time quantitative PCR
analysis was also performed on these tissues with TLR4-specific primers. Intriguingly, a distinct expression profile was observed. In contrast to TLR2, mean TLR4 mRNA levels in
endometrium tended to be higher than for other tissues and
were significantly different when comparing endometrium to
cervix and ectocervix (Fig. 4B and C). Moreover, there was a
progressive decline in TLR4 expression moving down the reproductive tract from endometrium to cervix to ectocervix
(Fig. 4B, C, and E). In fact, expression of TLR4 in ectocervix
was lower than that in any other tissue (Fig. 4 C, E and F). In
contrast to TLR2 expression, there was no significant difference between fallopian tube and endometrial TLR4 mRNA
levels (Fig. 4A). Representative data from a single patient are
shown in Fig. 5B.
Expression of TLR2 and TLR4 protein in tissues of the
female reproductive tract. Consistent with their roles in immune surveillance, we detected expression of TLR2 and TLR4
transcripts in tissues of the upper and lower female reproductive tract. To confirm proper posttranscriptional processing
and expression of these molecules, TLR2 and TLR4 were
immunoprecipitated from a random sampling of fallopian
tube, endometrium, and cervix and examined by immunoblot
analysis. As demonstrated in Fig. 6, TLR2 and TLR4 proteins
were expressed, to variable extents, in all three tissue types. In
each immunoblot, a specific band was detected that corresponded to the reported full-length moieties of TLR2 and
TLR4. The specificity of each antigen-antibody interaction was
confirmed by simultaneous immunoprecipitation with a P3

control antibody, followed by Western blot analysis for TLR2
and TLR4. Neither TLR2 nor TLR4 was nonspecifically immunoprecipitated by the P3 antibody (data not shown).
DISCUSSION
Recent studies have suggested that upper and lower tissues
of the female reproductive tract are phenotypically compartmentalized with respect to acquired immunity. For example,
functional studies with a model of Chlamydia trachomatis infection in mice indicated preferential recruitment of CD4⫹ T
lymphocytes to upper regions of the genital tract during infection (9). In addition, Yeaman et al. demonstrated the existence
of unique CD8⫹-T-cell-rich lymphoid aggregates in human
endometrium (33). In contrast, relatively little is known about
innate immune responses within the human female reproductive tract. Our findings are the first to characterize TLR expression in nontumorigenic complex tissues of the human female genital tract. We observed constitutive in vivo expression
of TLRs 1 to 6, MyD88, and the accessory molecules CD14 and
MD-2 in fallopian tube, endometrium, cervix, and ectocervix.
Real-time quantitative PCR demonstrated variable expression
of TLR2 and TLR4 among tissues of the upper and lower tract.
These differences likely occur through a variety of mechanisms
and may reflect adaptation of the innate immune response to
the distinct microbial milieu encountered by each tissue.
In this regard, it is imperative to consider the unique microenvironment of each female reproductive tract compartment.
The nonsterile lower tissues of the tract, the vagina and ectocervix, harbor a variety of commensal bacteria which maintain
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FIG. 4. TLR4 mRNA expression declines along tissues of the female reproductive tract. cDNA was synthesized by reverse transcription from
total RNA, and relative TLR4 mRNA levels were assessed by real-time PCR analysis with normalization to ␤-actin controls. Each reaction was
performed in duplicate. Comparisons among tissue types were made with paired tissue samples of the fallopian tube (FT), endometrium (EM),
cervix (CX), and ectocervix (ECX) derived from the same patients. The sample size for each comparison is indicated in the upper right quadrant
of each panel.

low vaginal pH (reviewed in reference 21). In addition to
sexually transmitted pathogenic challenges, these tissues are
subject to secondary contamination as a result of their proximity to rectal flora. The cervix, while not exposed to the same
breadth of microbiota as the vagina and ectocervix, is considered an immunologically dynamic site; cervical mucus provides

an impediment to sperm and bacterial infiltration of the uterus
(5). The most common cervical pathogens are the gram-negative bacteria Neisseria gonorrhoeae and Chlamydia trachomatis
(21). The uppermost section of the female reproductive tract
consists of the fallopian tube and endometrium. Although infection of these sites is uncommon, ascending pathogens (par-

FIG. 5. Representative analysis of TLR2 and TLR4 expression profiles. (A) Total RNA was extracted from fallopian tube (FT), endometrium
(EM), cervix (CX), and ectocervix (ECX) samples of patient 2532 and reverse transcribed with random hexamers. TLR2 levels were quantified
by real-time analysis with Taqman TLR2 primers and probes as in Fig. 3. (B) TLR4 mRNA levels were quantified in fallopian tube (FT),
endometrium (EM), cervix (CX), and ectocervix (ECX) samples derived from patient 2560 by real-time Taqman PCR as described for Fig. 4.
Reactions were standardized against ␤-actin and are expressed in relative fluorescence units (RFU). Values shown are the means of duplicate PCR
runs, which never varied by more than 3%.
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FIG. 6. Detection of TLR2 and TLR4 proteins in upper and lower tissues of the female reproductive tract. Whole-cell lysates were generated
from total tissue of the fallopian tube (FT), endometrium (EM), cervix (CX), and ectocervix (ECX) and quantified with the BCA kit. One
milligram of each of these lysates was immunoprecipitated with either (A) anti-TLR2 polyclonal antibody (H-175) or (B) mouse monoclonal
anti-TLR4 antibody (HTA 125), and subsequently probed with (A) goat polyclonal antibody N-17 for detection of TLR2 or (B) rabbit polyclonal
anti-TLR4 antibody H-80. Data shown are representative of three separate immunoprecipitations from three different tissues.

ticularly N. gonorrhoeae and C. trachomatis) may breach the
mucosal barrier of the cervix, resulting in adverse reproductive
consequences, including the development of pelvic inflammatory disease, tubal factor infertility, and ectopic pregnancy (2,
12, 27, 31).
Given the roles imputed to TLR2 and TLR4 in the regulation of innate immunity and response to bacterial challenge,
we examined quantitative expression of these pattern recognition receptors in tissues of the female genital tract. Our findings indicate that TLR2 is most highly expressed in fallopian
tubes and cervix, with lower levels present in endometrium and
ectocervix. TLR2 is activated by a broad spectrum of pathogen-associated molecular patterns, including peptidoglycan
from gram-positive bacteria, bacterial lipoproteins, mycobacterial cell wall lipoarabinomannan, and yeast cell walls (15, 17,
25). This diversity of ligands may account for the importance of
its elevated expression in fallopian tube and cervical tissue; less
apparent is the reduced TLR2 expression observed in the endometrium. It is possible that this expression pattern is related
to the role of the endometrium in the maintenance of an
environment hospitable to fetal implantation. Thus, TLR2 expression may be maintained at a low level in the healthy uterus
but be upregulated in response to pathogenic challenge as a
defense mechanism that can be mobilized to protect the fetus
from infection during pregnancy and labor. In this model,
TLR4 levels may be sufficiently high to preclude infection of
endometrium by organisms that are commonly encountered.
TLR2 expression, while constitutively low, would be inducible
postinfection. In fact, studies conducted by Watari et al. have
shown that TLR2 expression is augmented by tumor necrosis
factor alpha (29). Thus, TLR4 engagement, which results in
the production of tumor necrosis factor alpha, would precipitate a more vigorous inflammatory response subsequent to
increased expression of TLR2.
Intriguingly, TLR4 mRNA was most highly expressed in
fallopian tube and endometrium, tissues most likely to be challenged by gram-negative N. gonorrhoeae and C. trachomatis
(21). Increased innate surveillance at these sites (manifested by

increased TLR4 expression) may provide a means of ensuring
sterile conditions while conferring protection from microbial
challenge. The tissues of the lower tract, the cervix and ectocervix, which maintain a first line of defense for the female
reproductive tract, are exposed to a much broader variety of
infectious agents. The decreased expression of TLR4 associated with cervix and ectocervix is no doubt reflective of the
complex microbiota associated with these tissues. Clearly, it is
essential that these tissues develop a mechanism for selectively
responding to pathogens while avoiding chronic inflammation
due to immune responses to commensal bacteria. Limiting
TLR4 levels may provide a means of regulating sensitivity to
bacterial components in the lower tract.
Previous work conducted with primary human vaginal, endocervical, and ectocervical epithelial cells detected mRNA
expression of TLRs 1, 2, 3, 5, and 6 but failed to observe
expression of TLR4 and MD-2 (7). Although these cells were
unresponsive to protein-free preparations of lipopolysaccharide from Escherichia coli as well as lipooligosaccharide from
N. gonorrhoeae, they did mount inflammatory responses to
whole gram-negative bacteria and bacterial lysates (7). While
this study differs from ours in that we evaluated TLR expression in total tissue lysate as opposed to a single cell type, these
data are significant in light of our discovery that while TLR4
expression is low in cervical tissue, TLR2 mRNA levels are
relatively high (comparable to those observed in fallopian
tube). It is possible that under conditions of low TLR4 expression, TLR2 is activated, either because of redundant or alternative ligand recognition. This model is supported by a recent
report from Darville et al., in which recognition of C. trachomatis was shown to be mediated by TLR2 in TLR4 knockout
mice (4). In addition, TLR4-deficient gingival epithelial cells
respond to gram-negative bacteria via TLR2 ligands (1).
Recruitment of the adaptor protein MyD88 is critical for
most TLR-mediated signal transduction and activation of
NF-B and mitogen-activated protein kinase (25). Although
MyD88-independent signaling does occur, MyD88 is required
for lipopolysaccharide-induced tumor necrosis factor alpha
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TABLE 2. Summary of patient population
Patient
no.

Age
(yr)

Diagnosis

Postmenopausal

2497
2561
2549
2574
2490
2515
2583
2500

48
58
65
50
54
54
81
58

Endometrial hyperplasia
Endometrial hyperplasia
Prolapse
Fibroids
Prolapse
Menorrhagia
Prolapse
Prolapse

Proliferative

2560
2506
2567
2536
2535
2522
2527
2551

48
26
42
30
45
28
38
50

Fibroids
Pelvic pain
Pelvic mass
Pelvic pain
Dysmenorrhea
Cervical cancer
Pelvic pain
Menorrhagia

Secretory

2531
2521
2577
2502
2544
2542
2573
2539

41
34
44
48
37
35
41
38

Menorrhagia
Menorrhagia
Fibroids
Prolapse
Dysmenorrhea
Dysmenorrhea
Dysmenorrhea
Secretory

Unknown

2579
2511
2564
2532

47
38
51
58

Fibroids
Prolapse
Endometrial hyperplasia
Ovarian mass

Menstrual stage

5805

ence in TLR mRNA expression levels with respect to age for
our samples. There was similarly no significant correlation
between receptor expression and menstrual stage. These findings may be due to higher inherent TLR expression variability
among human subjects than in inbred mice and suggest that
evaluation of a much larger population will be necessary to
reveal potential expression differences that might exist in relation to age or hormonal status. It is also important to note
that our experiments were conducted with heterogeneous cell
populations and thus do not exclude the possibility that TLR
expression might differ with age and/or hormonal status in
distinct cell types.
In conclusion, we have demonstrated that TLRs 1 to 6 are
constitutively expressed in the human female reproductive
tract. The pattern recognition receptors TLR2 and TLR4 show
quantitatively distinct mRNA expression profiles among tissues of the female genital tract, and transcripts of these messages are expressed as proteins within the fallopian tubes,
endometrium, and cervix. This study is the first to comprehensively examine in vivo expression of TLRs 1 to 6 within the
human female reproductive tract. An enhanced understanding
of innate immune mechanisms within the female reproductive
tract and their role in bacterial recognition may provide insight
into the pathogenesis of sexually transmitted diseases and the
deleterious sequelae associated with genital tract inflammation.
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